ARCHIVES

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

This article is from The Cancer Letter archive.

Vol. 32 No. 28 | July 21, 2006

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008

Robert Young To Step Down As Fox Chase Cancer Center President in 2007.

September 29, 2006

Diet & Nutrition Workshops Planned

March 14, 1975

Rumors Preceded Broder’s Move

December 22, 1994

Advocacy: Groups Urge studies Of Environmental Pollutants As Cause Of Cancer

November 5, 1999